BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions with no assurance regarding its timing, size, or terms.
Net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Public Offering Announcement
BioSig Technologies intends to offer shares of common stock through an underwritten public offering.
Net Proceeds Usage
The company plans to use the net proceeds to purchase gold bullion, for working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering remains subject to market conditions.
- Interested parties should read the preliminary prospectus supplement and other related documents before investing in the offering.
BioSig Technologies' proposed public offering aims to raise capital to support its investment policy and corporate operations. The company's focus on gold bullion purchase highlights its strategic financial planning.